Natural health product · NPN 80075323
Beano®
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed January 27, 2017.
- Natural Product Number (NPN)
- 80075323
- Licence holder
- Medtech Products, Inc.Tarrytown, New York, United States
- Dosage form
- Tablet
- Route
- Oral
- Licensing route
- CompendialThe company attested that the product meets a Health Canada monograph.
- First licensed
- January 27, 2017
Also sold as
Other product names on the same licence.
- Beano Alpha-Galactosidase Enzyme Tablets
- Beano Enzyme Tablets
- Beano® Tablets
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| alpha-D-Galactoside galactohydrolase | 300 fcc alpha-galactosidase units | alpha-Galactosidase |
| alpha-D-Galactoside galactohydrolase | 5.2 milligrams | alpha-Galactosidase |
| alpha-D-Galactoside galactohydrolase | 300 fcc alpha-galactosidase units | Aspergillus niger - Whole |
| alpha-D-Galactoside galactohydrolase | 5.2 milligrams | Aspergillus niger - Whole |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Digestive enzyme. Helps prevent gastrointestinal intolerance of oligosaccharides/fermentable carbohydrates. Helps reduce gas production/flatulence following a meal rich in fermentable carbohydrates (such as vegetables, pulses/legumes/beans and whole grains.
Non-medicinal ingredients
Colloidal silicon dioxide; Magnesium stearate; Calcium gluconate; D-Mannitol; Microcrystalline cellulose; Potato starch